Stay updated on Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page.

Latest updates to the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision label was updated to v3.6.3, replacing the previous v3.6.2, reflecting a new software release.SummaryDifference0.1%

- Check8 days agoChange DetectedThe patch updates the page's revision label from v3.6.0 to v3.6.2, indicating a minor maintenance release without changes to study content or how the page is presented.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedVersion history now displays explicit Last verified and Last known status fields and adds a revision tag (v3.6.0). The previous labels Verified and Last known status were removed in favor of the updated metadata presentation.SummaryDifference3%

- Check29 days agoChange DetectedThe Record History shows a new revision tag v3.5.5, indicating a routine system update with no changes to study details or results.SummaryDifference0.1%

- Check51 days agoChange DetectedNew revision v3.5.4 is now listed in the study record versions, replacing the previous v3.5.3. The change updates the revision history to reflect the latest document version.SummaryDifference0.1%

- Check72 days agoChange DetectedThe developer revision/version displayed on the page was updated from v3.5.2 to v3.5.3, reflecting a backend/site release rather than a change to the trial’s record history.SummaryDifference0.1%

Stay in the know with updates to Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page.